drugset / Trial / NCT07322445
Multi-modal Imaging of Myofascial Pain - Phase 2
Recruiting
100 enrolled
Washington University School of Medicine
National Center for Complementary and Integrative Health (NCCIH) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The goal of this study is to evaluate imaging biomarkers for quantitative assessments of myofascial pain and determine their ability to monitor treatment response and predict clinical outcomes.
Timeline
- Start
- 2025-10-01
- Primary completion
- 2027-08
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupivacaine | Other / unclassified | 0.25 % | Other |
| Comparator | Lidocaine | Other / unclassified | 1 % | Other |